A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease (MASLD), defined by the presence of liver steatosis together with at least one out of five cardiometabolic factors, is the most common cause of chronic liver disease worldwide, affecting around one in three people. Yet the clinical presentatio...
Main Authors: | Maria Jimenez Ramos, Timothy J. Kendall, Ignat Drozdov, Jonathan A. Fallowfield |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268123003812 |
Similar Items
-
A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease
by: Javier Martínez-Sanz, et al.
Published: (2023-12-01) -
From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
by: Ming-Lun Yeh, et al.
Published: (2023-10-01) -
Cross talk between the liver microbiome and epigenome in patients with metabolic dysfunction-associated steatotic liver diseaseResearch in context
by: Carlos Jose Pirola, et al.
Published: (2024-03-01) -
Associating Appendicitis with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Novel Insight into an Unexpected Connection
by: Christoph Roderburg, et al.
Published: (2024-02-01) -
Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics
by: Gary Huang, et al.
Published: (2023-10-01)